PHK
KRYS icon

Point72 Hong Kong’s Krystal Biotech KRYS Stock Holding History

Point72 Hong Kong’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-2,276
Closed -$119K – 2151
2021
Q3 		$119K Buy
2,276
+2,232
+5,073% +$132K ﹤0.01% 1300
2021
Q2 		$3K Buy
+44
New +$3.07K ﹤0.01% 1820
2020
Q3 		– Sell
-172
Closed -$7K – 1366
2020
Q2 		$7K Buy
+172
New +$8.28K ﹤0.01% 1015

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Hong Kong's KRYS Position: Q4 2021 in Review

Point72 Hong Kong sold out of Krystal Biotech (KRYS) in Q4 2021, closing a stake of 2,276 shares — an estimated $119K sold.

Point72 Hong Kong first reported a position in KRYS in Q2 2020 and held it in 3 quarters. The position peaked at $119K in Q3 2021. 140 funds tracked by Wall St. Rank hold KRYS as of Q4 2021.

  • Point72 Hong Kong reported no remaining Krystal Biotech position as of Q4 2021 after selling out during the quarter.
  • Point72 Hong Kong sold 2,276 Krystal Biotech shares in Q4 2021, an estimated $119K.
  • Point72 Hong Kong first reported a position in Krystal Biotech in Q2 2020 and held it in 3 quarters.
  • Point72 Hong Kong's Krystal Biotech position peaked at $119K in Q3 2021.
  • 140 funds tracked by Wall St. Rank held Krystal Biotech as of Q4 2021.

Based on Point72 Hong Kong's 13F filing for Q4 2021, filed 14 Feb 2022.